Patient experiences with pulmonary fibrosis

Respiratory Medicine

Volumn 101, Issue 6, 2007, Pages 1350-1354

  Collard, Harold R ^a   Tino, Gregory ^b   Noble, Paul W ^c   Shreve, Mark A ^d   Michaels, Maureen ^e   Carlson, Bruce ^e   Schwarz, Marvin I ^f  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d Patient Outreach and Advocacy Coalition for Pulmonary Fibrosis   (United States)

^e Michaels Opinion Research Inc   (United States)

^f UNIVERSITY OF COLORADO   (United States)

Author keywords

Diagnosis; Management; Patient; Pulmonary fibrosis; Survey

Indexed keywords

AZATHIOPRINE; COLCHICINE; CYCLOPHOSPHAMIDE; GAMMA1B INTERFERON; HERBACEOUS AGENT; OXYGEN; PREDNISONE;

ADULT; AGED; ARTICLE; BRONCHOSCOPY; CONTROLLED STUDY; DIET SUPPLEMENTATION; FEMALE; HEALTH SURVEY; HUMAN; LUNG BIOPSY; LUNG FIBROSIS; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; OXYGEN THERAPY; PATIENT ATTITUDE; PATIENT EDUCATION; PERSONAL EXPERIENCE; PHYSIOTHERAPY; PRIORITY JOURNAL; PULMONARY REHABILITATION; QUESTIONNAIRE;

AGED; ATTITUDE TO HEALTH; FEMALE; HEALTH SERVICES RESEARCH; HUMANS; MALE; MIDDLE AGED; PATIENT EDUCATION; PATIENT PARTICIPATION; PATIENT SATISFACTION; PULMONARY FIBROSIS; UNITED STATES;

EID: 34247570651     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2006.10.002     Document Type: Article

References (16)

1. Flaherty K.R., King Jr. T.E., Raghu G., et al. Idiopathic interstitial pneumonia: what is the effect of a multidisciplinary approach to diagnosis?. Am J Respir Crit Care Med 170 8 (2004) 904-910
2. American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med 161 (2000) 646-664
3. Collard H.R., and King Jr. T.E. Demystifying idiopathic interstitial pneumonia. Arch Intern Med 163 1 (2003) 17-29
4. Douglas W.W., Ryu J.H., and Schroeder D.R. Idiopathic pulmonary fibrosis: impact of oxygen and colchicine, prednisone, or no therapy on survival. Am J Respir Crit Care Med 161 4, Part 1 (2000) 1172-1178
5. Bjoraker J.A., Ryu J.H., Edwin M.K., et al. Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 157 (1998) 199-203
6. Flaherty K.R., Toews G.B., Travis W.D., et al. Clinical significance of histological classification of idiopathic interstitial pneumonia. Eur Respir J 19 2 (2002) 275-283
7. Nicholson A.G., Colby T.V., Dubois R.M., Hansell D.M., and Wells A.U. The prognostic significance of the histologic pattern of interstitial pneumonia in patients presenting with the clinical entity of cryptogenic fibrosing alveolitis. Am J Respir Crit Care Med 162 (2000) 2213-2217
8. Hunninghake G., Zimmerman M.B., Schwartz D.A., et al. Utility of lung biopsy for the diagnosis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 164 (2001) 193-196
9. Raghu G., Mageto Y.N., Lockhart D., et al. The accuracy of the clinical diagnosis of new-onset idiopathic pulmonary fibrosis and other interstitial lung disease: a prospective study. Chest 116 5 (1999) 1168-1174
10. Collard H.R., King Jr. T.E., Bartelson B.B., et al. Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 168 5 (2003) 538-542
11. Flaherty K.R., Mumford J.A., Murray S., et al. Prognostic implications of physiologic and radiographic changes in idiopathic interstitial pneumonia. Am J Respir Crit Care Med 168 5 (2003) 543-548
12. Latsi P.I., du Bois R.M., Nicholson A.G., et al. Fibrotic idiopathic interstitial pneumonia: the prognostic value of longitudinal functional trends. Am J Respir Crit Care Med 168 5 (2003) 531-537
13. Smith C.M., and Moser K.M. Management for interstitial lung disease: state of the art. Chest 95 3 (1989) 676-678
14. Johnston I.D., Prescott R.J., Chalmers J.C., and Rudd R.M. British Thoracic Society study of cryptogenic fibrosing alveolitis: current presentation and initial management. Fibrosing Alveolitis Subcommittee of the Research Committee of the British Thoracic Society. Thorax 52 1 (1997) 38-44
15. Swigris J.J., Kuschner W.G., Jacobs S.S., Wilson S.R., and Gould M.K. Health-related quality of life in patients with idiopathic pulmonary fibrosis: a systematic review. Thorax 60 7 (2005) 588-594
16. Swigris J.J., Stewart A.L., Gould M.K., and Wilson S.R. Patients' perspectives on how idiopathic pulmonary fibrosis affects the quality of their lives. Health Qual Life Outcomes 3 (2005) 61